首页> 外文OA文献 >PMS58 CLINICAL OUTCOMES AND CHANGES IN QUALITY OF LIFE IN WOMEN WITH OSTEOPOROSIS TREATED WITH TERIPARATIDE: 36 MONTH RESULTS OF THE FRENCH PATIENTS PARTICIPATING IN THE EUROPEAN FORSTEO OBSERVATIONAL STUDY (EFOS)

【2h】

PMS58 CLINICAL OUTCOMES AND CHANGES IN QUALITY OF LIFE IN WOMEN WITH OSTEOPOROSIS TREATED WITH TERIPARATIDE: 36 MONTH RESULTS OF THE FRENCH PATIENTS PARTICIPATING IN THE EUROPEAN FORSTEO OBSERVATIONAL STUDY (EFOS)

机译：PMS58接受特立哌肽治疗的骨质疏松症妇女的临床疗效和生活质量变化：参加欧洲STEO观察的法国患者36个月的结果

代理获取

本网站仅为用户提供外文OA文献查询和代理获取服务，本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文，但由于OA文献来源多样且变更频繁，仍可能出现获取不到、文献不完整或与标题不符等情况，如果获取不到我们将提供退款服务。请知悉。

页面导航

著录项
引文网络
相似文献
相关主题

著录项

作者
Rajzbaum G; Tcherny-Lessenot S; liu-Leage S; Gehchan N; Barrett A;
展开▼
作者单位

展开▼
年度 2010
总页数
原文格式 PDF
正文语种
中图分类

相似文献

外文文献
中文文献

1. Effectiveness of teriparatide in women over 75 years of age with severe osteoporosis: 36-month results from the European Forsteo Observational Study (EFOS) [J] . WalshJ.B., LemsW.F., KarrasD., Calcified tissue international. . 2012,第5期

机译：特立帕肽对75岁以上严重骨质疏松症妇女的有效性：欧洲Forsteo观察研究（EFOS）的36个月结果
2. Effectiveness of Teriparatide in Women Over 75 Years of Age with Severe Osteoporosis: 36-Month Results from the European Forsteo Observational Study (EFOS) [J] . J. Bernard Walsh, Willem F. Lems, Dimitrios Karras, Calcified Tissue International . 2012,第5期

机译：特立帕肽对75岁以上严重骨质疏松症妇女的有效性：欧洲Forsteo观察研究（EFOS）的36个月结果
3. Reduction in fracture rate and back pain and increased quality of life in postmenopausal women treated with teriparatide: 18-month data from the European Forsteo Observational Study (EFOS). [J] . Langdahl BL, Rajzbaum G, Jakob Calcified tissue international. . 2009,第6期

机译：接受特立帕肽治疗的绝经后妇女的骨折率和背部疼痛的降低以及生活质量的提高：来自欧洲Forsteo观察研究（EFOS）的18个月数据。
4. A retrospective study of the relationship between chronological age and the self-perceived quality of life among renal dialysis patients through administration and measurement by the SF-36 Quality of Life Questionnaire. [D] . Soleimani, Ghazal. 2005

机译：通过SF-36生活质量调查问卷进行管理和测量，对肾脏透析患者的年龄和其自我感知的生活质量之间的关系进行回顾性研究。
5. Effectiveness of Teriparatide in Women Over 75 Years of Age with Severe Osteoporosis: 36-Month Results from the European Forsteo Observational Study (EFOS) [O] . J. Bernard Walsh, Willem F. Lems, Dimitrios Karras, -1

机译：特立帕肽对75岁以上严重骨质疏松症妇女的有效性：欧洲Forsteo观察研究（EFOS）的36个月结果
6. PMS50 FRACTURE INCIDENCE AND CHANGES IN QUALITY OF LIFE AND BACK PAIN INWOMEN WITH OSTEOPOROSIS TREATED WITH TERIPARATIDE: EUROPEAN FORSTEO OBSERVATIONAL STUDY (EFOS) 18 MONTH RESULTS FROM PATIENTS ENROLLED IN FRANCE [O] . Rajzbaum G, Tcherny-Lessenot S, Liu-Leage S, 2008

机译：特立哌肽治疗的骨质疏松症患者的PMS50骨折发生率和生活质量和背部疼痛的变化：欧洲的骨肉观察研究（EFOS）法国患者入组18个月的结果

PMS58 CLINICAL OUTCOMES AND CHANGES IN QUALITY OF LIFE IN WOMEN WITH OSTEOPOROSIS TREATED WITH TERIPARATIDE: 36 MONTH RESULTS OF THE FRENCH PATIENTS PARTICIPATING IN THE EUROPEAN FORSTEO OBSERVATIONAL STUDY (EFOS)

著录项

引文网络

相似文献

相关主题

期刊订阅